Navan is perhaps the most high-profile IPO over the past month, as the SEC's filing process has stalled with 90% of staff furloughed.

Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 ...

Wall Street is licking its chops at the mere prospect of an OpenAI IPO, which could unleash a financial frenzy with little ...

Medline disclosed on Tuesday that its revenue rose 9.7% in the first half of 2025, as one of the world's largest makers of ...

According to a filing with the Securities and Exchange Commission dated October 20, 2025, Renaissance Capital reported a new ...

Discover how book building helps underwriters price IPOs effectively by gauging investor interest and demand. Learn why it's the preferred method over fixed pricing.

With the shutdown ongoing, Evommune plans to close its IPO on Nov. 5 via a Securities Act clause that allows registrations to ...

The trajectory of the Lenskart IPO GMP shows how exuberance has given way to caution, with the market asking for a bit more ...

Founded only nine months ago, the company plans to build a Texas-based 'HyperGrid' and become a provider of data and power ...

OpenAI is preparing for a $1 trillion IPO that could launch in 2026. The ChatGPT maker plans to raise at least $60 billion ...

The Lenskart valuation of Rs 70,000 crore indicates a PE ratio of 230. Netizens pointed out that this was contrary to what ...

While Tuhin Kanta Pandey didn't provide a specific timeline, his assertion suggests that hurdles holding up the NSE listing ...